• Vaccines

Tenivac Generic Name & Formulations

General Description

Tetanus and diphtheria toxoids; aluminum adsorbed; susp for IM inj; preservative-free.

Pharmacological Class

Td vaccine.

How Supplied

Single-dose vials (0.5mL)—10
Single-dose prefilled syringe (0.5mL)—10


Tenivac Indications


Tetanus and diphtheria immunization in patients >7yrs.

Tenivac Dosage and Administration

Adults and Children

<7yrs: not established. >7yrs: Give IM in deltoid muscle. Previously unvaccinated: three 0.5mL doses, administer first two doses 2 months apart and then third dose 6–8 months after second dose. Routine booster: give at 11–12yrs of age and every 10 years thereafter. Diphtheria and tetanus prophylaxis: see full labeling.

Tenivac Contraindications


Anaphylaxis associated with a previous dose.

Tenivac Boxed Warnings

Not Applicable

Tenivac Warnings/Precautions


Guillain-Barre syndrome within 6 weeks of previous tetanus toxoid vaccine. Previous Arthus-type hypersensitivity reaction: not recommended until ≥10yrs after prior dose of tetanus toxoid-containing vaccine. Immunodeficiency. Have epinephrine (1:1000) available. Latex allergy (syringe tip cap). Pregnancy (Cat.C). Nursing mothers.

Tenivac Pharmacokinetics

See Literature

Tenivac Interactions


Concomitant tetanus immune globulin (human): inject at separate site with separate needle and syringe if passive protection required. Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may get suboptimal response.

Tenivac Adverse Reactions

Adverse Reactions

Injection site reactions (eg, pain, redness, swelling), headache, malaise, muscle weakness, joint pain.

Tenivac Clinical Trials

See Literature

Tenivac Note

Not Applicable

Tenivac Patient Counseling

See Literature